ARCHIVES

Platinum-Free Break Enhances Therapy After First Relapse In Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 3 | March 28, 2003

Download PDF Visit The Full Archive

Related Articles

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

June 26, 2013

Tests Find No Conclusive Evidence On Two Chemicals

September 21, 1979

Informatics: Gore Helps NCI Open CGAP Website

August 8, 1997

In Brief: Hawaii Center Searching For New Director: Rosenberg Denies Report He’s Going To Tampa

June 7, 1985

NCI-Approved Trials Listed

April 28, 2006

NCCN’s First Physician CEO: Robert Carlson Pledges Broader Research and Policy Agenda

October 5, 2012